Simplify Logo

Full-Time

Research Associate

Molecular Immunology

Confirmed live in the last 24 hours

Orbital Therapeutics

Orbital Therapeutics

51-200 employees

Develops RNA-based medicines and therapies

Biotechnology
Healthcare

Junior, Mid

Cambridge, MA, USA

Category
Lab & Research
Medical Research
Required Skills
Data Analysis
Requirements
  • B.S. or M.S. in Immunology, Biology, or related field.
  • Must have 1-4 years of industry or academic based experience.
  • Extensive experience in designing and executing molecular immunology experiments.
  • Experience working with cell culture, including primary cells, required.
  • Experience with ELISA, MSD, BLI and functional cell-based assays required.
  • Experience maintaining accurate records of experimental data in electronic lab notebook (ELN) format.
  • Understanding of statistical principles as applicable to data analysis.
  • Execution focused, team-oriented, and highly motivated with strong written and oral presentation skills.
Responsibilities
  • Work both independently and as part of a team to design and conduct studies to characterize antibodies and antibody-like proteins using techniques such as ELISA, MSD, BLI, and functional cell-based assays.
  • Culture cells with sterile technique and perform transfections into immortalized and primary cell lines.
  • Assist with developing new cell-based and biochemical assays including troubleshooting and coming up with creative solutions.
  • Maintain an organized inventory and detailed record of all experiments and important reagents in the lab.
  • Clearly communicate findings as well as challenges that arise in a timely manner.
  • Help shape R&D strategy and contribute meaningfully to building out our internal efforts to advance our autoimmune and immune-oncology programs at the forefront of scientific innovation.

Orbital Therapeutics focuses on developing RNA-based medicines, specifically targeting areas like vaccines, immunomodulation, and protein replacement. The company utilizes RNA technology, advanced delivery methods, data science, and automation to create a platform for a wide range of therapeutic applications. Unlike many competitors, Orbital Therapeutics does not work with small interfering RNA, allowing it to carve out a unique niche in the genetic medicine space. The goal is to enhance global health by harnessing RNA medicines to treat diseases in innovative ways that were not possible before. Revenue is generated through the sale of these medicines to healthcare providers, who then administer them to patients.

Company Stage

Series A

Total Funding

$320M

Headquarters

San Francisco, California

Founded

2022

Growth & Insights
Headcount

6 month growth

12%

1 year growth

3%

2 year growth

454%
Simplify Jobs

Simplify's Take

What believers are saying

  • Securing $270 million in Series A financing provides substantial capital to advance their RNA-based therapeutic platform.
  • The company's focus on next-generation vaccines, immunomodulation, and protein replacement positions it at the forefront of innovative treatments for various diseases.
  • Strategic partnerships, such as with Beam Therapeutics, enhance Orbital's capabilities in RNA and delivery technologies, broadening their therapeutic applications.

What critics are saying

  • The highly competitive field of RNA-based medicines requires continuous innovation to maintain a leading position.
  • The complexity of developing and commercializing RNA-based therapies could lead to longer timelines and higher costs.

What makes Orbital Therapeutics unique

  • Orbital Therapeutics focuses exclusively on RNA-based medicines, excluding small interfering RNA, which sets it apart from other genetic medicine companies.
  • The company leverages a unique combination of RNA technology, delivery methods, data science, and automation to create a versatile platform for developing a broad range of medicines.
  • The leadership team, including Dr. Giuseppe Ciaramella, brings extensive experience in drug discovery and biotherapeutics, providing a strategic advantage in the competitive landscape.